Why HCA Healthcare (HCA) Could Be 42% Below Fair Value Following Its Guidance Cut
HCA Healthcare (HCA) cut its full year 2026 earnings guidance after a payer mix shift increased uninsured patient volumes, pressuring income even as Medicaid Supplemental Payment Programs partially offset the impact.
See our latest analysis for HCA Healthcare.
The guidance cut hit sentiment hard, with HCA Healthcare’s 1 day share price return falling about 7% and its 7 day share price return down roughly 14%, contributing to a year to date share price decline of about 23%. Even so, the 3 year total shareholder return of about 28% and 5 year total shareholder return of about 52% show that long term holders have still seen positive outcomes despite recent pressure.
If this shift in HCA Healthcare’s outlook has you reassessing your health focused ideas, it may be a good time to see what else is moving in specialist healthcare technology by exploring 40 healthcare AI stocks
Bulls see HCA Healthcare’s payer mix hit and sharp share price fall as a chance to back a large, cash generative hospital operator at a discount, while bears focus on guidance cuts. Which case does the valuation lean toward next?
Most Popular Narrative: 42.2% Undervalued
Compared with HCA Healthcare’s last close at $363.60, the most followed narrative places fair value materially higher, framing the recent guidance cut against a longer term cash generation story.
In a market that often swings between hype and fear, HCA Healthcare (NYSE: HCA) stands out for a different reason: consistency. While much of the healthcare sector wrestles with reimbursement uncertainty, labor costs, and regulatory noise, HCA continues to operate from a position of scale and operational discipline. It’s not flashy, but it’s effective.
What sits behind that higher fair value is not a moonshot, but a model built on steady revenue expansion, disciplined margins, and a measured discount rate. The tension is how those ingredients, combined with HCA Healthcare’s scale, can still support a valuation far above today’s price.
Result: Fair Value of $629.14 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, HCA Healthcare still faces risks if uninsured volumes stay elevated or if reimbursement support, including Medicaid Supplemental Payment Programs, weakens from current levels.
Find out about the key risks to this HCA Healthcare narrative.
Next Steps
With sentiment clearly split on HCA Healthcare, this is a moment to act fast and test the story against the numbers yourself using the 5 key rewards and 2 important warning signs.
Looking for more investment ideas beyond HCA Healthcare?
If HCA Healthcare’s recent moves have you rethinking your next step, do not sit on the sidelines while other opportunities line up on your radar.
- Target potential mispricings by reviewing companies highlighted in the 44 high quality undervalued stocks for ideas that might not yet be fully appreciated.
- Strengthen your income stream by checking out stocks in the 8 dividend fortresses that offer higher yields with a focus on resilience.
- Prioritize resilience and capital protection by scanning companies in the 79 resilient stocks with low risk scores that score well on stability and downside risk.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com